The Best of 2020: The RA Report


Read this supplement to Rheumatology News here.

In this issue :

  • Synovial biopsy findings drive precision medicine closer to the clinic
  • Ready for PRIME time? Newly identified cells predict flares
  • Rheumatologists’ prescriptions of biosimilars stagnate
  • Methotrexate in terms of ILD concerns, poor adherence, and low-dose AEs 10-13 TNF inhibitors linked to risk for inflammatory CNS events
  • Hypersensitivity reactions to biologics differentiated
  • Repeat latent TB testing focuses on new risks

Read More Now

Recommended Reading

Are diagnosticians chasing COVID-linked zebras and missing horses?
MDedge Rheumatology
U.K. COVID-19 variant doubling every 10 days in the U.S.: Study
MDedge Rheumatology
Women increasingly turn to CBD, with or without doc’s blessing
MDedge Rheumatology
TNF inhibitors may slow spinal progression in axial spondyloarthritis
MDedge Rheumatology
Teenagers get in the queue for COVID-19 vaccines
MDedge Rheumatology